Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This
clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long
term among clinically stable patients. The study will also assess the long term effectiveness
of lurasidone as compared to an active comparator.